Recurrent Loss of NFE2L2 Exon 2 Is a Mechanism for Nrf2 Pathway Activation in Human Cancers

Cell Reports - Tập 16 - Trang 2605-2617 - 2016
Leonard D. Goldstein1,2, James Lee3, Florian Gnad2, Christiaan Klijn2, Annalisa Schaub3, Jens Reeder2, Anneleen Daemen2, Corey E. Bakalarski2,4, Thomas Holcomb5, David S. Shames5, Ryan J. Hartmaier6, Juliann Chmielecki6, Somasekar Seshagiri1, Robert Gentleman2, David Stokoe3
1Department of Molecular Biology, Genentech Inc., South San Francisco, CA 94080, USA
2Department of Bioinformatics and Computational Biology, Genentech, Inc., South San Francisco, CA 94080, USA
3Department of Discovery Oncology, Genentech Inc., South San Francisco, CA 94080, USA
4Department of Protein Chemistry, Genentech, Inc., South San Francisco, CA 94080, USA
5Department of Oncology Biomarker Development, Genentech, Inc., South San Francisco, CA 94080, USA
6Foundation Medicine, Inc. Cambridge, MA 02141, USA

Tài liệu tham khảo

An, 2015, Truncated ERG oncoproteins from TMPRSS2-ERG fusions are resistant to SPOP-mediated proteasome degradation, Mol. Cell, 59, 904, 10.1016/j.molcel.2015.07.025 Anders, 2010, Differential expression analysis for sequence count data, Genome Biol., 11, R106, 10.1186/gb-2010-11-10-r106 Baba, 2013, Seven in absentia homolog 2 (Siah2) protein is a regulator of NF-E2-related factor 2 (Nrf2), J. Biol. Chem., 288, 18393, 10.1074/jbc.M112.438762 2012, Comprehensive genomic characterization of squamous cell lung cancers, Nature, 489, 519, 10.1038/nature11404 2014, Comprehensive molecular profiling of lung adenocarcinoma, Nature, 511, 543, 10.1038/nature13385 Cerami, 2012, The cBio Cancer Genomics Portal: an open platform for exploring multidimensional cancer genomics data, Cancer Discov., 2, 401, 10.1158/2159-8290.CD-12-0095 Cho, 2011, Glioblastoma-derived epidermal growth factor receptor carboxyl-terminal deletion mutants are transforming and are sensitive to EGFR-directed therapies, Cancer Res., 71, 7587, 10.1158/0008-5472.CAN-11-0821 Chorley, 2012, Identification of novel NRF2-regulated genes by ChIP-seq: influence on retinoid X receptor alpha, Nucleic Acids Res., 40, 7416, 10.1093/nar/gks409 Chowdhry, 2013, Nrf2 is controlled by two distinct β-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity, Oncogene, 32, 3765, 10.1038/onc.2012.388 DeNicola, 2015, NRF2 regulates serine biosynthesis in non-small cell lung cancer, Nat. Genet., 47, 1475, 10.1038/ng.3421 Frampton, 2013, Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing, Nat. Biotechnol., 31, 1023, 10.1038/nbt.2696 Fukutomi, 2014, Kinetic, thermodynamic, and structural characterizations of the association between Nrf2-DLGex degron and Keap1, Mol. Cell. Biol., 34, 832, 10.1128/MCB.01191-13 Gao, 2013, Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal, Sci. Signal., 6, pl1, 10.1126/scisignal.2004088 George, 2015, Comprehensive genomic profiles of small cell lung cancer, Nature, 524, 47, 10.1038/nature14664 Goldstein, 2016, Prediction and Quantification of Splice Events from RNA-Seq Data, PLoS ONE, 11, e0156132, 10.1371/journal.pone.0156132 2015, Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans, Science, 348, 648, 10.1126/science.1262110 Hart, 1999, The F-box protein beta-TrCP associates with phosphorylated beta-catenin and regulates its activity in the cell, Curr. Biol., 9, 207, 10.1016/S0960-9822(99)80091-8 Hirotsu, 2012, Nrf2-MafG heterodimers contribute globally to antioxidant and metabolic networks, Nucleic Acids Res., 40, 10228, 10.1093/nar/gks827 Imielinski, 2012, Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing, Cell, 150, 1107, 10.1016/j.cell.2012.08.029 Itoh, 1999, Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain, Genes Dev., 13, 76, 10.1101/gad.13.1.76 Iwao, 1998, Activation of the beta-catenin gene by interstitial deletions involving exon 3 in primary colorectal carcinomas without adenomatous polyposis coli mutations, Cancer Res., 58, 1021 Kataoka, 2015, Integrated molecular analysis of adult T cell leukemia/lymphoma, Nat. Genet., 47, 1304, 10.1038/ng.3415 Katoh, 2001, Two domains of Nrf2 cooperatively bind CBP, a CREB binding protein, and synergistically activate transcription, Genes Cells, 6, 857, 10.1046/j.1365-2443.2001.00469.x Klijn, 2015, A comprehensive transcriptional portrait of human cancer cell lines, Nat. Biotechnol., 33, 306, 10.1038/nbt.3080 Kong-Beltran, 2006, Somatic mutations lead to an oncogenic deletion of met in lung cancer, Cancer Res., 66, 283, 10.1158/0008-5472.CAN-05-2749 Law, 2014, voom: Precision weights unlock linear model analysis tools for RNA-seq read counts, Genome Biol., 15, R29, 10.1186/gb-2014-15-2-r29 Leinonen, 2014, Role of the Keap1-Nrf2 pathway in cancer, Adv. Cancer Res., 122, 281, 10.1016/B978-0-12-420117-0.00008-6 MacLeod, 2009, Characterization of the cancer chemopreventive NRF2-dependent gene battery in human keratinocytes: demonstration that the KEAP1-NRF2 pathway, and not the BACH1-NRF2 pathway, controls cytoprotection against electrophiles as well as redox-cycling compounds, Carcinogenesis, 30, 1571, 10.1093/carcin/bgp176 Malhotra, 2010, Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChIP-seq profiling and network analysis, Nucleic Acids Res., 38, 5718, 10.1093/nar/gkq212 McMahon, 2006, Dimerization of substrate adaptors can facilitate cullin-mediated ubiquitylation of proteins by a “tethering” mechanism: a two-site interaction model for the Nrf2-Keap1 complex, J. Biol. Chem., 281, 24756, 10.1074/jbc.M601119200 Pruitt, 2005, NCBI Reference Sequence (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins, Nucleic Acids Res., 33, D501, 10.1093/nar/gki025 Riccardi, 2006, Analysis of apoptosis by propidium iodide staining and flow cytometry, Nat. Protoc., 1, 1458, 10.1038/nprot.2006.238 Rosenbloom, 2015, The UCSC Genome Browser database: 2015 update, Nucleic Acids Res., 43, D670, 10.1093/nar/gku1177 Sekine, 2015, The mediator subunit MED16 transduces NRF2-activating signals into antioxidant gene expression, Mol. Cell. Biol., 36, 407, 10.1128/MCB.00785-15 Shibata, 2008, Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy, Proc. Natl. Acad. Sci. USA, 105, 13568, 10.1073/pnas.0806268105 Tong, 2006, Keap1 recruits Neh2 through binding to ETGE and DLG motifs: characterization of the two-site molecular recognition model, Mol. Cell. Biol., 26, 2887, 10.1128/MCB.26.8.2887-2900.2006 Tong, 2006, Two-site substrate recognition model for the Keap1-Nrf2 system: a hinge and latch mechanism, Biol. Chem., 387, 1311, 10.1515/BC.2006.164 Vitari, 2011, COP1 is a tumour suppressor that causes degradation of ETS transcription factors, Nature, 474, 403, 10.1038/nature10005 Vogelstein, 2013, Cancer genome landscapes, Science, 339, 1546, 10.1126/science.1235122 Wu, 2010, Fast and SNP-tolerant detection of complex variants and splicing in short reads, Bioinformatics, 26, 873, 10.1093/bioinformatics/btq057 Zhang, 2006, BRG1 interacts with Nrf2 to selectively mediate HO-1 induction in response to oxidative stress, Mol. Cell. Biol., 26, 7942, 10.1128/MCB.00700-06